Autoimmune Disease | Helminth parasites / their by-products | Model | Outcomes | References |
---|---|---|---|---|
Type 1 Diabetes (T1D) | Schistosoma mansoni soluble egg/worm antigen | Non-obese Diabetic (NOD) mice | Effective when administered at 4Â weeks of age. Causes decrease interleukin-12 (IL-12) and increase IL-10 production | [32] |
Trichinella spiralis | NOD mice | Provides protection mainly by a prejudiced Th2 response coupled with an IL-10 response | [33] | |
Heligmosomoides polygyrus | Streptozotocin (STZ)-induced T1D mouse model | Protective effects against hyperglycemia and decrease in pancreatic islet size through Th2 independent mechanisms | [34] | |
Fasciola hepatica excretory secretory antigen | NOD mice | Promotes interferon-γ (IFN-γ) suppression and modulates macrophage activity | [35] | |
Litomosoides sigmodontis antigen | NOD mice | Antigen administration with intranasal pro-insulin dose increases Treg cell frequency and decreases pancreatic islet inflammation | [36] | |
Brugia malayi antigen | STZ induced T1D mouse model | rBmALT-2 decreases tumour necrosis factor-α (TNF-α) and IFN-γ levels, and increases IL-4, IL-5, and IL-10 production by splenocytes | [18] | |
Schistosoma japonicum antigen (Cystatin and fructose-1,6-bisphosphate aldolase) | NOD mice | Disease amelioration by decreasing IFN-γ and increasing Th2 cytokines, Tregs, IL-10 and TGF-β | [37] | |
Rheumatoid arthritis (RA) | Nippostrongylus brasiliensis | Murphy Roths Large (MRL) lpr mice | Parasitic infections decrease the incidence and severity of arthritis. Increased serum concentration of IL-4 and IgG1Â are noted | [38] |
Fasciola gigantica somatic antigen (Fg-Ag) and Gigantocotyle explanatum (Ge-Ag) somatic antigen | Collagen induced arthritis (CIA) rats | Therapeutically, Ge-Ag is more effective than Fg-Ag, demonstrated by reducted serum TNF-α and IFN-γ levels and increased serum IL-4 and IL-10 levels | [39] | |
Schistosoma mansoni | IL-1 receptor antagonist (IL-1Ra)-deficient mice | Mitigates disease impact by decreasing IL-17 and TNF-α while increasing IL-4 and IL-10 splenic responses | [40] | |
Acanthocheilonema viteae ES-62 | CIA mice | Downregulation of IL-1β and decrease in inflammasome activity at the site of infection | ||
Schistosoma japonicum peptide SJMHE1 | DBA/1 J mice | Peptides with minimal side effects effectively suppress collagen-induced arthritis symptoms by downregulating IFN-γ, TNF-α, IL−6, IL-17, and IL-22, and upregulating IL-10 and CD4+ Tregs | [42] | |
Clonorchis sinensis metacercariae | CIA mice | Aggravated arthritis due to increased neutrophils and monocytes while decreased B cells and CD4+ T cells count | [19] | |
Trichinella spiralis MES | CIA mice | ES products inhibit M1 macrophage polarization and proinflammatory cytokines in CIA mice, thereby reducing bone destruction and inhibits osteoclastogenesis in infected joints | [43] | |
Multiple sclerosis (MS) | Schistosoma mansoni ova | Experimental Autoimmune Encephalomyelitis (EAE) Mice | Immune response polarization; decrease in IFN-r, TNF-α, IL-12, and increase in IL-4, IL-10, and TGF-β; Th2 response was observed | [44] |
Schistosoma japonicum Soluble Egg Antigen (SEA) | EAE Mice | Ameliorates disease by decreasing IFN-γ and increasing IL-4 production in the CNS and spleen | [45] | |
Taenia crassiceps | EAE Mice | Decreases IL-17 and TNF-α production and increases IL-4 and IL-10 production | [46] | |
Toxascaris leonina recombinant galectin (rTl-gal) | EAE Mice | Prevents EAE remission by markedly increasing CD45R/B220+B cell numbers and decreasing TNF-α and IFN-γ | [47] | |
Fasciola hepatica FhHDM-1 peptide | NOD/Lt mice | Ameliorates disease by reducing the secretion of pro-inflammatory cytokines such as TNF and IL-6 | [48] | |
Inflammatory Bowel Disease (IBD) | Schistosoma mansoni egg antigen | Dextran sodium sulfate (DSS) induced colitis in mice | It reduces disease effect by increasing FoxP3+ T regulatory cells and Th2 cytokine production | [49] |
Heligmosomoides polygyrus ES 55Â kDa antigen | DSS induced colitis in BALB/c mice | Antigen treatment modulates IL-10 production, thereby reducing inflammation caused by DSS-induced colitis | [50] | |
Hymenolepis diminuta | DNBS induced colitis in BALB/c mice | The helminth-infected mice showed increased IL-4 and IL-10 production | [51] | |
Trichinella spiralis Cystatin | Trinitrobenzene sulfonic acid (TNBS) induced colitis in BALB/c mice | Protection was achieved via an induced Th2-type response | [52] | |
Hymenolepis diminuta | Dinitrobenzene sulfonic acid (DNBS) induced colitis in mice | A skewed Th2 response was observed | [53] | |
Schistosoma japonicum peptide SJMHE1 | C57BL/6 mice | The peptide demonstrates protective effects against both acute and chronic colitis induced by DSS | [20] | |
Echinococcus granulosus sensu strict and Antigen B | DSS infected BALB/c mice | A reduction in clinical symptoms was achieved owing to increased F4/80+Â CD206+ and decreased F4/80+Â CD11c+ in the intestine | [54] | |
Clonorchis sinensis cysteine proteases (rCsCP and CsCA) | DSS induced colitis in mice | Ameliorates colitis by upregulating IL-4, IL-10, and IL-13 and downregulating IL-12b, IL-23r, IL-7, and IL-17A production | [55] |